

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | drug transport (GO:0015893) | 9.24941839 |
| 2 | * urate metabolic process (GO:0046415) | 9.23940443 |
| 3 | collecting duct development (GO:0072044) | 9.16798347 |
| 4 | organic cation transport (GO:0015695) | 8.81230500 |
| 5 | phosphate ion transport (GO:0006817) | 8.54849636 |
| 6 | lysine catabolic process (GO:0006554) | 8.06828903 |
| 7 | lysine metabolic process (GO:0006553) | 8.06828903 |
| 8 | actin filament depolymerization (GO:0030042) | 8.01794576 |
| 9 | exogenous drug catabolic process (GO:0042738) | 7.61292581 |
| 10 | drug catabolic process (GO:0042737) | 7.51389444 |
| 11 | quaternary ammonium group transport (GO:0015697) | 7.14389852 |
| 12 | phosphate ion transmembrane transport (GO:0035435) | 7.09985990 |
| 13 | glyoxylate metabolic process (GO:0046487) | 6.93448426 |
| 14 | cysteine metabolic process (GO:0006534) | 6.72413316 |
| 15 | cardiovascular system development (GO:0072358) | 6.37183761 |
| 16 | nephron tubule formation (GO:0072079) | 6.28647872 |
| 17 | response to mercury ion (GO:0046689) | 6.18646090 |
| 18 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 6.14710069 |
| 19 | tricarboxylic acid metabolic process (GO:0072350) | 6.12622425 |
| 20 | nonribosomal peptide biosynthetic process (GO:0019184) | 6.08344600 |
| 21 | response to water (GO:0009415) | 5.88112431 |
| 22 | excretion (GO:0007588) | 5.83425228 |
| 23 | vitamin D metabolic process (GO:0042359) | 5.79603095 |
| 24 | negative regulation of metanephros development (GO:0072217) | 5.70522816 |
| 25 | toxin transport (GO:1901998) | 5.61548704 |
| 26 | cell volume homeostasis (GO:0006884) | 5.57628670 |
| 27 | short-chain fatty acid metabolic process (GO:0046459) | 5.54907657 |
| 28 | glutathione biosynthetic process (GO:0006750) | 5.48992164 |
| 29 | renal absorption (GO:0070293) | 5.45443746 |
| 30 | aspartate family amino acid catabolic process (GO:0009068) | 5.44662203 |
| 31 | positive regulation of catenin import into nucleus (GO:0035413) | 5.39119111 |
| 32 | branched-chain amino acid metabolic process (GO:0009081) | 5.29298991 |
| 33 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.23483343 |
| 34 | metanephric nephron tubule development (GO:0072234) | 5.21501673 |
| 35 | metanephric tubule development (GO:0072170) | 5.21501673 |
| 36 | trivalent inorganic anion homeostasis (GO:0072506) | 5.21380809 |
| 37 | phosphate ion homeostasis (GO:0055062) | 5.21380809 |
| 38 | amino-acid betaine transport (GO:0015838) | 5.10636536 |
| 39 | carnitine transport (GO:0015879) | 5.10636536 |
| 40 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 5.07444109 |
| 41 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 5.06112127 |
| 42 | negative regulation of sterol transport (GO:0032372) | 5.05920596 |
| 43 | negative regulation of cholesterol transport (GO:0032375) | 5.05920596 |
| 44 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 5.02830151 |
| 45 | glycoside metabolic process (GO:0016137) | 4.93933154 |
| 46 | L-phenylalanine metabolic process (GO:0006558) | 4.88337729 |
| 47 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.88337729 |
| 48 | valine metabolic process (GO:0006573) | 4.87570966 |
| 49 | homocysteine metabolic process (GO:0050667) | 4.84597100 |
| 50 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.83274031 |
| 51 | L-phenylalanine catabolic process (GO:0006559) | 4.83274031 |
| 52 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 4.81993130 |
| 53 | metanephric nephron epithelium development (GO:0072243) | 4.80066884 |
| 54 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 4.75766088 |
| 55 | modified amino acid transport (GO:0072337) | 4.74284074 |
| 56 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 4.72542703 |
| 57 | serine family amino acid catabolic process (GO:0009071) | 4.71797843 |
| 58 | serine family amino acid metabolic process (GO:0009069) | 4.71170120 |
| 59 | cellular modified amino acid catabolic process (GO:0042219) | 4.70006652 |
| 60 | proline metabolic process (GO:0006560) | 4.65440158 |
| 61 | aromatic amino acid family catabolic process (GO:0009074) | 4.64019149 |
| 62 | response to thyroid hormone (GO:0097066) | 4.61514584 |
| 63 | amino-acid betaine metabolic process (GO:0006577) | 4.49869423 |
| 64 | indole-containing compound catabolic process (GO:0042436) | 4.43483986 |
| 65 | indolalkylamine catabolic process (GO:0046218) | 4.43483986 |
| 66 | tryptophan catabolic process (GO:0006569) | 4.43483986 |
| 67 | fatty acid beta-oxidation (GO:0006635) | 4.40555057 |
| 68 | peptide biosynthetic process (GO:0043043) | 4.40019325 |
| 69 | metanephric epithelium development (GO:0072207) | 4.38732077 |
| 70 | response to vitamin A (GO:0033189) | 4.34933499 |
| 71 | branched-chain amino acid catabolic process (GO:0009083) | 4.30948596 |
| 72 | 2-oxoglutarate metabolic process (GO:0006103) | 4.27220419 |
| 73 | fructose metabolic process (GO:0006000) | 4.26083731 |
| 74 | tryptophan metabolic process (GO:0006568) | 4.25480860 |
| 75 | pattern specification involved in kidney development (GO:0061004) | 4.19905454 |
| 76 | nephron tubule development (GO:0072080) | 4.17148757 |
| 77 | response to copper ion (GO:0046688) | 4.16790584 |
| 78 | positive regulation of glomerulus development (GO:0090193) | 4.10631540 |
| 79 | carnitine metabolic process (GO:0009437) | 4.10173565 |
| 80 | cellular ketone body metabolic process (GO:0046950) | 4.07420114 |
| 81 | sodium-independent organic anion transport (GO:0043252) | 4.06941129 |
| 82 | oligosaccharide catabolic process (GO:0009313) | 4.06055207 |
| 83 | bone remodeling (GO:0046849) | 4.06032181 |
| 84 | peptide catabolic process (GO:0043171) | 4.03939722 |
| 85 | fatty acid oxidation (GO:0019395) | 4.03822315 |
| 86 | hyperosmotic response (GO:0006972) | 4.01765213 |
| 87 | acetyl-CoA metabolic process (GO:0006084) | 3.97294414 |
| 88 | lipid oxidation (GO:0034440) | 3.96272124 |
| 89 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 3.93802699 |
| 90 | serine family amino acid biosynthetic process (GO:0009070) | 3.88365043 |
| 91 | response to parathyroid hormone (GO:0071107) | 3.85577877 |
| 92 | response to phenylpropanoid (GO:0080184) | 3.80322873 |
| 93 | NADH metabolic process (GO:0006734) | 3.79143075 |
| 94 | glutathione metabolic process (GO:0006749) | 3.76802142 |
| 95 | glutamate metabolic process (GO:0006536) | 3.74629672 |
| 96 | response to growth hormone (GO:0060416) | 3.73664517 |
| 97 | cellular amino acid catabolic process (GO:0009063) | 3.72975310 |
| 98 | renal system process (GO:0003014) | 3.70841833 |
| 99 | renal tubule development (GO:0061326) | 3.70264790 |
| 100 | vitamin transport (GO:0051180) | 3.66136985 |
| 101 | inositol metabolic process (GO:0006020) | 3.64386696 |
| 102 | urogenital system development (GO:0001655) | 3.64044943 |
| 103 | fatty acid catabolic process (GO:0009062) | 3.62923610 |
| 104 | cell differentiation involved in metanephros development (GO:0072202) | 3.61877928 |
| 105 | alpha-amino acid catabolic process (GO:1901606) | 3.58926924 |
| 106 | regulation of protein localization to cell surface (GO:2000008) | 3.58013770 |
| 107 | drug metabolic process (GO:0017144) | 3.57785895 |
| 108 | cellular response to ammonium ion (GO:0071242) | 3.56040084 |
| 109 | regulation of cholesterol efflux (GO:0010874) | 3.54996696 |
| 110 | indole-containing compound metabolic process (GO:0042430) | 3.54819476 |
| 111 | glutathione derivative biosynthetic process (GO:1901687) | 3.52951622 |
| 112 | glutathione derivative metabolic process (GO:1901685) | 3.52951622 |
| 113 | ketone body metabolic process (GO:1902224) | 3.50312487 |
| 114 | beta-amyloid metabolic process (GO:0050435) | 3.49670589 |
| 115 | aromatic amino acid family metabolic process (GO:0009072) | 3.44616928 |
| 116 | cellular response to vitamin D (GO:0071305) | 3.44204260 |
| 117 | organic acid catabolic process (GO:0016054) | 3.41487822 |
| 118 | carboxylic acid catabolic process (GO:0046395) | 3.41487822 |
| 119 | nephron tubule morphogenesis (GO:0072078) | 3.41155852 |
| 120 | nephron epithelium morphogenesis (GO:0072088) | 3.41155852 |
| 121 | monocarboxylic acid catabolic process (GO:0072329) | 3.41032275 |
| 122 | sulfur amino acid catabolic process (GO:0000098) | 3.40505340 |
| 123 | nephron epithelium development (GO:0072009) | 3.37097323 |
| 124 | sulfur compound transport (GO:0072348) | 3.34141893 |
| 125 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.31617727 |
| 126 | response to magnesium ion (GO:0032026) | 3.30207843 |
| 127 | sodium ion transport (GO:0006814) | 3.26711501 |
| 128 | response to lead ion (GO:0010288) | 3.24777956 |
| 129 | mammary gland alveolus development (GO:0060749) | 3.24677285 |
| 130 | dicarboxylic acid metabolic process (GO:0043648) | 3.24664270 |
| 131 | tricarboxylic acid cycle (GO:0006099) | 3.23873332 |
| 132 | response to salt stress (GO:0009651) | 3.21821870 |
| 133 | mesonephros development (GO:0001823) | 3.19384090 |
| 134 | negative regulation of kidney development (GO:0090185) | 3.16581729 |
| 135 | positive regulation of metanephros development (GO:0072216) | 3.10067203 |
| 136 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 3.03289589 |
| 137 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 3.02985704 |
| 138 | regulation of fever generation (GO:0031620) | 3.02312221 |
| 139 | regulation of mesenchymal cell apoptotic process (GO:2001053) | 2.97561403 |
| 140 | metanephric mesenchyme development (GO:0072075) | 2.96717920 |
| 141 | regulation of epithelial cell differentiation involved in kidney development (GO:2000696) | 2.96661670 |
| 142 | glomerular visceral epithelial cell development (GO:0072015) | 2.95467606 |
| 143 | one-carbon compound transport (GO:0019755) | 2.95341584 |
| 144 | positive regulation of heat generation (GO:0031652) | 2.94294947 |
| 145 | ERK1 and ERK2 cascade (GO:0070371) | 2.93535768 |
| 146 | response to lithium ion (GO:0010226) | 2.92305285 |
| 147 | water transport (GO:0006833) | 2.89495100 |
| 148 | regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 2.87614621 |
| 149 | regulation of anion transport (GO:0044070) | 2.87240124 |
| 150 | regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2 | 2.84656320 |
| 151 | regulation of metanephros development (GO:0072215) | 2.84066412 |
| 152 | regulation of catenin import into nucleus (GO:0035412) | 2.73963294 |
| 153 | neurotransmitter biosynthetic process (GO:0042136) | 2.72201820 |
| 154 | positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742) | 2.68127904 |
| 155 | inorganic anion transport (GO:0015698) | 2.65377771 |
| 156 | regulation of stem cell maintenance (GO:2000036) | 2.64593953 |
| 157 | glycine metabolic process (GO:0006544) | 2.64501095 |
| 158 | S-adenosylmethionine metabolic process (GO:0046500) | 2.64372675 |
| 159 | protein depolymerization (GO:0051261) | 2.63327168 |
| 160 | negative regulation of lipid transport (GO:0032369) | 2.63177699 |
| 161 | regulation of glomerulus development (GO:0090192) | 2.63038078 |
| 162 | positive regulation of peptidyl-threonine phosphorylation (GO:0010800) | 2.62986917 |
| 163 | oxaloacetate metabolic process (GO:0006107) | 2.62733476 |
| 164 | polyol transport (GO:0015791) | 11.4894532 |
| 165 | drug transmembrane transport (GO:0006855) | 11.0808101 |
| 166 | aminoglycoside antibiotic metabolic process (GO:0030647) | 11.0020572 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.34868080 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.30359330 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.50404537 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.11546866 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.85286087 |
| 6 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.72912757 |
| 7 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.66865151 |
| 8 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.86514609 |
| 9 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.78396347 |
| 10 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.60594634 |
| 11 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.60149912 |
| 12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.55127804 |
| 13 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.37385523 |
| 14 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.34830454 |
| 15 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.32967554 |
| 16 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.30886979 |
| 17 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.25791837 |
| 18 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.19706525 |
| 19 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.15291515 |
| 20 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.04345977 |
| 21 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.02471171 |
| 22 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.98329317 |
| 23 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.85100668 |
| 24 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.84830749 |
| 25 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.82292122 |
| 26 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.80781234 |
| 27 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.78912653 |
| 28 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.78347449 |
| 29 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.75493730 |
| 30 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.74041980 |
| 31 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.66968389 |
| 32 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.66591673 |
| 33 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.66119507 |
| 34 | VDR_22108803_ChIP-Seq_LS180_Human | 1.63634177 |
| 35 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.57441977 |
| 36 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.54402316 |
| 37 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.54294770 |
| 38 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.51408227 |
| 39 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.51408227 |
| 40 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.51323285 |
| 41 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.50137964 |
| 42 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.49798451 |
| 43 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.48173341 |
| 44 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.47871153 |
| 45 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.46544197 |
| 46 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.46458069 |
| 47 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.45037366 |
| 48 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.42218082 |
| 49 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.40614168 |
| 50 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.40081952 |
| 51 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.37943928 |
| 52 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.36223178 |
| 53 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.34326279 |
| 54 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.33318264 |
| 55 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.33140253 |
| 56 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.31599615 |
| 57 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.31423452 |
| 58 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.31402888 |
| 59 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.30366679 |
| 60 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.25618050 |
| 61 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.22843115 |
| 62 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.21536424 |
| 63 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.20531323 |
| 64 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.20392831 |
| 65 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.20204421 |
| 66 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.18115159 |
| 67 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.17778967 |
| 68 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.16922499 |
| 69 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16626904 |
| 70 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.16572940 |
| 71 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.16572940 |
| 72 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.15434179 |
| 73 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.15229270 |
| 74 | RXR_22108803_ChIP-Seq_LS180_Human | 1.09941301 |
| 75 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.09246635 |
| 76 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.08971800 |
| 77 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.08072373 |
| 78 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.07372570 |
| 79 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.06855792 |
| 80 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.06759996 |
| 81 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.05800429 |
| 82 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.04399624 |
| 83 | P300_19829295_ChIP-Seq_ESCs_Human | 1.04100303 |
| 84 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.03785288 |
| 85 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.02864554 |
| 86 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.02607441 |
| 87 | TBL1_22424771_ChIP-Seq_293T_Human | 1.01125544 |
| 88 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.01038113 |
| 89 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 1.00880757 |
| 90 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.00530149 |
| 91 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.00244058 |
| 92 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.00149765 |
| 93 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.99806383 |
| 94 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.99796286 |
| 95 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.99033338 |
| 96 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.98790163 |
| 97 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.98695048 |
| 98 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.97735622 |
| 99 | SOX11_22085726_ChIP-Seq_ESNs_Mouse | 0.97117967 |
| 100 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.96345816 |
| 101 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.96334520 |
| 102 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.96239522 |
| 103 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.96123062 |
| 104 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.95751884 |
| 105 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.95642737 |
| 106 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.94683083 |
| 107 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.94469058 |
| 108 | * KDM2B_26808549_Chip-Seq_REH_Human | 0.94442432 |
| 109 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.93061896 |
| 110 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.92619176 |
| 111 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.91753691 |
| 112 | NFYA_21822215_ChIP-Seq_K562_Human | 0.91303635 |
| 113 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.90985531 |
| 114 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.90544006 |
| 115 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.90426337 |
| 116 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.89986409 |
| 117 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.89255828 |
| 118 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.89096676 |
| 119 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.88477379 |
| 120 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.88380308 |
| 121 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88360815 |
| 122 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.88044873 |
| 123 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.87454603 |
| 124 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.87035769 |
| 125 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.86961503 |
| 126 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.86769390 |
| 127 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.85858495 |
| 128 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.85144717 |
| 129 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.83454687 |
| 130 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.83076092 |
| 131 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.83007640 |
| 132 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.82609588 |
| 133 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.82266569 |
| 134 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.82008310 |
| 135 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.80165216 |
| 136 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.79404174 |
| 137 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.78315365 |
| 138 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.77558710 |
| 139 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.77339623 |
| 140 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.77313341 |
| 141 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.76953577 |
| 142 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.76423219 |
| 143 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.76297661 |
| 144 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.75768142 |
| 145 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.75100724 |
| 146 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.74912329 |
| 147 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.73099062 |
| 148 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.71404708 |
| 149 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.71075231 |
| 150 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.70402247 |
| 151 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.70216107 |
| 152 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.70167387 |
| 153 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.70077696 |
| 154 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.69101492 |
| 155 | GATA2_19941826_ChIP-Seq_K562_Human | 0.68494857 |
| 156 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.67302450 |
| 157 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.67055750 |
| 158 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.66376338 |
| 159 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.65466661 |
| 160 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.65446229 |
| 161 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.65359442 |
| 162 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.64930276 |
| 163 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.64850385 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 7.66748627 |
| 2 | MP0004043_abnormal_pH_regulation | 6.53042554 |
| 3 | MP0004019_abnormal_vitamin_homeostasis | 5.09931119 |
| 4 | MP0005332_abnormal_amino_acid | 4.96517713 |
| 5 | MP0002139_abnormal_hepatobiliary_system | 4.84945596 |
| 6 | MP0003195_calcinosis | 4.10810546 |
| 7 | MP0002138_abnormal_hepatobiliary_system | 4.07653536 |
| 8 | MP0001765_abnormal_ion_homeostasis | 3.90105259 |
| 9 | * MP0009643_abnormal_urine_homeostasis | 3.81160010 |
| 10 | MP0005636_abnormal_mineral_homeostasis | 3.19232200 |
| 11 | MP0001756_abnormal_urination | 3.03197273 |
| 12 | MP0005377_hearing/vestibular/ear_phenot | 3.02248240 |
| 13 | MP0003878_abnormal_ear_physiology | 3.02248240 |
| 14 | MP0008875_abnormal_xenobiotic_pharmacok | 2.99780861 |
| 15 | * MP0002136_abnormal_kidney_physiology | 2.84056185 |
| 16 | MP0001958_emphysema | 2.77841873 |
| 17 | MP0003252_abnormal_bile_duct | 2.53171640 |
| 18 | MP0005365_abnormal_bile_salt | 2.29343848 |
| 19 | MP0005085_abnormal_gallbladder_physiolo | 2.22102863 |
| 20 | MP0005058_abnormal_lysosome_morphology | 2.19141742 |
| 21 | MP0003186_abnormal_redox_activity | 1.79872535 |
| 22 | MP0008961_abnormal_basal_metabolism | 1.73476694 |
| 23 | MP0004885_abnormal_endolymph | 1.72764919 |
| 24 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.68090735 |
| 25 | MP0000538_abnormal_urinary_bladder | 1.62007230 |
| 26 | MP0001270_distended_abdomen | 1.57113330 |
| 27 | MP0000534_abnormal_ureter_morphology | 1.51387956 |
| 28 | MP0005084_abnormal_gallbladder_morpholo | 1.46689018 |
| 29 | MP0003300_gastrointestinal_ulcer | 1.39168241 |
| 30 | MP0005319_abnormal_enzyme/_coenzyme | 1.38147430 |
| 31 | MP0003806_abnormal_nucleotide_metabolis | 1.36779539 |
| 32 | MP0005451_abnormal_body_composition | 1.36463000 |
| 33 | MP0002928_abnormal_bile_duct | 1.34747570 |
| 34 | MP0002876_abnormal_thyroid_physiology | 1.27421439 |
| 35 | MP0002168_other_aberrant_phenotype | 1.26402591 |
| 36 | MP0006036_abnormal_mitochondrial_physio | 1.25678386 |
| 37 | MP0003011_delayed_dark_adaptation | 1.19999434 |
| 38 | MP0000230_abnormal_systemic_arterial | 1.18276988 |
| 39 | MP0004147_increased_porphyrin_level | 1.11287533 |
| 40 | MP0002135_abnormal_kidney_morphology | 1.08506852 |
| 41 | MP0005535_abnormal_body_temperature | 1.07104278 |
| 42 | MP0005670_abnormal_white_adipose | 1.06886385 |
| 43 | MP0002896_abnormal_bone_mineralization | 1.03399012 |
| 44 | MP0002089_abnormal_postnatal_growth/wei | 0.99549498 |
| 45 | MP0008872_abnormal_physiological_respon | 0.99204164 |
| 46 | MP0004130_abnormal_muscle_cell | 0.98798488 |
| 47 | MP0001764_abnormal_homeostasis | 0.96028042 |
| 48 | MP0003172_abnormal_lysosome_physiology | 0.95872973 |
| 49 | MP0005666_abnormal_adipose_tissue | 0.95728199 |
| 50 | MP0003283_abnormal_digestive_organ | 0.94424336 |
| 51 | MP0008004_abnormal_stomach_pH | 0.93980853 |
| 52 | MP0003045_fibrosis | 0.92651542 |
| 53 | MP0001666_abnormal_nutrient_absorption | 0.88421926 |
| 54 | MP0002118_abnormal_lipid_homeostasis | 0.87832449 |
| 55 | MP0004264_abnormal_extraembryonic_tissu | 0.86371886 |
| 56 | MP0003646_muscle_fatigue | 0.81345040 |
| 57 | MP0003638_abnormal_response/metabolism_ | 0.80927037 |
| 58 | MP0003191_abnormal_cellular_cholesterol | 0.80338657 |
| 59 | MP0000747_muscle_weakness | 0.74856316 |
| 60 | MP0001661_extended_life_span | 0.74539500 |
| 61 | * MP0009642_abnormal_blood_homeostasis | 0.72294399 |
| 62 | MP0010234_abnormal_vibrissa_follicle | 0.71009794 |
| 63 | MP0005220_abnormal_exocrine_pancreas | 0.66610040 |
| 64 | MP0009764_decreased_sensitivity_to | 0.66539514 |
| 65 | MP0005083_abnormal_biliary_tract | 0.64583941 |
| 66 | MP0000371_diluted_coat_color | 0.63864355 |
| 67 | MP0005395_other_phenotype | 0.62887456 |
| 68 | MP0002796_impaired_skin_barrier | 0.62302284 |
| 69 | MP0001485_abnormal_pinna_reflex | 0.61593046 |
| 70 | MP0000609_abnormal_liver_physiology | 0.61513029 |
| 71 | MP0010329_abnormal_lipoprotein_level | 0.58908842 |
| 72 | MP0003879_abnormal_hair_cell | 0.56094506 |
| 73 | MP0003959_abnormal_lean_body | 0.56081500 |
| 74 | MP0002108_abnormal_muscle_morphology | 0.53933161 |
| 75 | MP0008469_abnormal_protein_level | 0.53808357 |
| 76 | MP0002115_abnormal_skeleton_extremities | 0.53067273 |
| 77 | MP0000598_abnormal_liver_morphology | 0.52073009 |
| 78 | MP0003329_amyloid_beta_deposits | 0.51536854 |
| 79 | MP0006035_abnormal_mitochondrial_morpho | 0.51527468 |
| 80 | MP0004742_abnormal_vestibular_system | 0.51444378 |
| 81 | MP0000678_abnormal_parathyroid_gland | 0.50927560 |
| 82 | MP0003938_abnormal_ear_development | 0.50817406 |
| 83 | MP0009115_abnormal_fat_cell | 0.50524455 |
| 84 | MP0005501_abnormal_skin_physiology | 0.50513225 |
| 85 | MP0005452_abnormal_adipose_tissue | 0.49390382 |
| 86 | MP0002998_abnormal_bone_remodeling | 0.48946756 |
| 87 | MP0002970_abnormal_white_adipose | 0.46829723 |
| 88 | MP0005408_hypopigmentation | 0.46549256 |
| 89 | MP0003795_abnormal_bone_structure | 0.46189614 |
| 90 | MP0009053_abnormal_anal_canal | 0.46063069 |
| 91 | MP0002078_abnormal_glucose_homeostasis | 0.46006197 |
| 92 | MP0003953_abnormal_hormone_level | 0.44956343 |
| 93 | MP0005334_abnormal_fat_pad | 0.44231921 |
| 94 | MP0000026_abnormal_inner_ear | 0.44205978 |
| 95 | MP0005165_increased_susceptibility_to | 0.43495418 |
| 96 | MP0002069_abnormal_eating/drinking_beha | 0.43006758 |
| 97 | MP0010386_abnormal_urinary_bladder | 0.42126157 |
| 98 | MP0005645_abnormal_hypothalamus_physiol | 0.41343148 |
| 99 | MP0003942_abnormal_urinary_system | 0.39802177 |
| 100 | MP0000163_abnormal_cartilage_morphology | 0.39219039 |
| 101 | MP0005375_adipose_tissue_phenotype | 0.39070804 |
| 102 | MP0004858_abnormal_nervous_system | 0.38856823 |
| 103 | MP0002132_abnormal_respiratory_system | 0.37736400 |
| 104 | MP0004484_altered_response_of | 0.37138955 |
| 105 | MP0001944_abnormal_pancreas_morphology | 0.37063883 |
| 106 | MP0001663_abnormal_digestive_system | 0.36667497 |
| 107 | MP0004272_abnormal_basement_membrane | 0.36248120 |
| 108 | MP0005379_endocrine/exocrine_gland_phen | 0.35815563 |
| 109 | MP0002638_abnormal_pupillary_reflex | 0.35260103 |
| 110 | MP0010368_abnormal_lymphatic_system | 0.34978825 |
| 111 | MP0005448_abnormal_energy_balance | 0.34534823 |
| 112 | MP0009672_abnormal_birth_weight | 0.34251888 |
| 113 | MP0001963_abnormal_hearing_physiology | 0.33812217 |
| 114 | MP0001191_abnormal_skin_condition | 0.33706146 |
| 115 | MP0002098_abnormal_vibrissa_morphology | 0.33444304 |
| 116 | MP0004215_abnormal_myocardial_fiber | 0.33405897 |
| 117 | MP0003221_abnormal_cardiomyocyte_apopto | 0.33159627 |
| 118 | MP0000566_synostosis | 0.32986349 |
| 119 | MP0000631_abnormal_neuroendocrine_gland | 0.32920919 |
| 120 | MP0001177_atelectasis | 0.32587795 |
| 121 | MP0006138_congestive_heart_failure | 0.32330712 |
| 122 | MP0005167_abnormal_blood-brain_barrier | 0.32261751 |
| 123 | MP0001731_abnormal_postnatal_growth | 0.30623638 |
| 124 | MP0009780_abnormal_chondrocyte_physiolo | 0.28202274 |
| 125 | MP0005647_abnormal_sex_gland | 0.27443804 |
| 126 | MP0000467_abnormal_esophagus_morphology | 0.26767675 |
| 127 | MP0002971_abnormal_brown_adipose | 0.26277951 |
| 128 | MP0009703_decreased_birth_body | 0.26165553 |
| 129 | MP0005275_abnormal_skin_tensile | 0.25008225 |
| 130 | MP0002113_abnormal_skeleton_development | 0.24984819 |
| 131 | MP0000003_abnormal_adipose_tissue | 0.24848583 |
| 132 | MP0000920_abnormal_myelination | 0.24365556 |
| 133 | MP0003724_increased_susceptibility_to | 0.24240178 |
| 134 | MP0001664_abnormal_digestion | 0.23805904 |
| 135 | MP0003303_peritoneal_inflammation | 0.23713186 |
| 136 | MP0005646_abnormal_pituitary_gland | 0.22075377 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased circulating renin level (HP:0000848) | 7.95912513 |
| 2 | Hypokalemic alkalosis (HP:0001949) | 7.33732421 |
| 3 | Metabolic alkalosis (HP:0200114) | 7.23462292 |
| 4 | Hypomagnesemia (HP:0002917) | 6.92609455 |
| 5 | Gout (HP:0001997) | 6.88951372 |
| 6 | Hyperactive renin-angiotensin system (HP:0000841) | 6.76024616 |
| 7 | Polyuria (HP:0000103) | 6.63251997 |
| 8 | Abnormality of chloride homeostasis (HP:0011422) | 6.23578960 |
| 9 | Abnormal urine output (HP:0012590) | 6.21876212 |
| 10 | Abnormality of renal excretion (HP:0011036) | 5.96915610 |
| 11 | Abnormality of magnesium homeostasis (HP:0004921) | 5.86244996 |
| 12 | Proximal tubulopathy (HP:0000114) | 5.62970316 |
| 13 | Abnormal drinking behavior (HP:0030082) | 5.37230078 |
| 14 | Polydipsia (HP:0001959) | 5.37230078 |
| 15 | Increased purine levels (HP:0004368) | 4.92398844 |
| 16 | Hyperuricemia (HP:0002149) | 4.92398844 |
| 17 | Tetany (HP:0001281) | 4.84748551 |
| 18 | Abnormality of renin-angiotensin system (HP:0000847) | 4.84163032 |
| 19 | Alkalosis (HP:0001948) | 4.79112826 |
| 20 | Renal salt wasting (HP:0000127) | 4.68157322 |
| 21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.65441191 |
| 22 | Hyperaldosteronism (HP:0000859) | 4.62452262 |
| 23 | Hyperglycinuria (HP:0003108) | 4.56120957 |
| 24 | Generalized aminoaciduria (HP:0002909) | 4.22480773 |
| 25 | Hypercalciuria (HP:0002150) | 4.16023432 |
| 26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.78312237 |
| 27 | Abnormality of glycine metabolism (HP:0010895) | 3.78312237 |
| 28 | Glycosuria (HP:0003076) | 3.77172160 |
| 29 | Abnormality of urine glucose concentration (HP:0011016) | 3.77172160 |
| 30 | Hypokalemia (HP:0002900) | 3.69619291 |
| 31 | Ketoacidosis (HP:0001993) | 3.66550595 |
| 32 | Renal tubular acidosis (HP:0001947) | 3.59814799 |
| 33 | * Abnormality of purine metabolism (HP:0004352) | 3.49574227 |
| 34 | Hyperphosphaturia (HP:0003109) | 3.37042984 |
| 35 | Delayed epiphyseal ossification (HP:0002663) | 3.26552019 |
| 36 | Ketosis (HP:0001946) | 3.22650076 |
| 37 | Large eyes (HP:0001090) | 3.19437797 |
| 38 | Abnormal urine phosphate concentration (HP:0012599) | 3.19091595 |
| 39 | Abnormality of potassium homeostasis (HP:0011042) | 3.12161963 |
| 40 | Nephrocalcinosis (HP:0000121) | 3.04724746 |
| 41 | Hydroxyprolinuria (HP:0003080) | 3.01288989 |
| 42 | Abnormality of proline metabolism (HP:0010907) | 3.01288989 |
| 43 | Generalized muscle weakness (HP:0003324) | 2.96260195 |
| 44 | Hypophosphatemia (HP:0002148) | 2.78207539 |
| 45 | Vascular calcification (HP:0004934) | 2.75051212 |
| 46 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.74980215 |
| 47 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.69916946 |
| 48 | Hyperglycinemia (HP:0002154) | 2.66044974 |
| 49 | Rickets (HP:0002748) | 2.63364993 |
| 50 | * Abnormality of nucleobase metabolism (HP:0010932) | 2.62045695 |
| 51 | Metaphyseal cupping (HP:0003021) | 2.61820955 |
| 52 | Delayed CNS myelination (HP:0002188) | 2.60124139 |
| 53 | Vacuolated lymphocytes (HP:0001922) | 2.58478912 |
| 54 | Widely patent fontanelles and sutures (HP:0004492) | 2.51240952 |
| 55 | * Nephrolithiasis (HP:0000787) | 2.50033470 |
| 56 | Dehydration (HP:0001944) | 2.45614945 |
| 57 | Cardiovascular calcification (HP:0011915) | 2.45336494 |
| 58 | Hyperammonemia (HP:0001987) | 2.37081564 |
| 59 | Abnormality of renal resorption (HP:0011038) | 2.33427939 |
| 60 | Hyponatremia (HP:0002902) | 2.32984966 |
| 61 | Dicarboxylic aciduria (HP:0003215) | 2.32587695 |
| 62 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.32587695 |
| 63 | Enlarged kidneys (HP:0000105) | 2.31208619 |
| 64 | Abnormality of sodium homeostasis (HP:0010931) | 2.29061147 |
| 65 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.27984393 |
| 66 | Metabolic acidosis (HP:0001942) | 2.24561440 |
| 67 | Vomiting (HP:0002013) | 2.24459274 |
| 68 | Confusion (HP:0001289) | 2.23206997 |
| 69 | Renal tubular dysfunction (HP:0000124) | 2.22363302 |
| 70 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.21874031 |
| 71 | Thin bony cortex (HP:0002753) | 2.20381781 |
| 72 | Malnutrition (HP:0004395) | 2.10993080 |
| 73 | Adrenal overactivity (HP:0002717) | 2.10198092 |
| 74 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.07937723 |
| 75 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.07151640 |
| 76 | Impaired platelet aggregation (HP:0003540) | 2.07018854 |
| 77 | Abnormal platelet function (HP:0011869) | 2.07018854 |
| 78 | Abnormal tarsal ossification (HP:0008369) | 2.05690709 |
| 79 | Methylmalonic aciduria (HP:0012120) | 2.02635802 |
| 80 | Tubulointerstitial fibrosis (HP:0005576) | 2.01232091 |
| 81 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.00357043 |
| 82 | Lethargy (HP:0001254) | 1.99845818 |
| 83 | Potter facies (HP:0002009) | 1.95697353 |
| 84 | Facial shape deformation (HP:0011334) | 1.95697353 |
| 85 | Tubular atrophy (HP:0000092) | 1.95352933 |
| 86 | Chondrocalcinosis (HP:0000934) | 1.95132887 |
| 87 | Lymphangioma (HP:0100764) | 1.89929668 |
| 88 | Bicornuate uterus (HP:0000813) | 1.89913018 |
| 89 | Abnormality of the costochondral junction (HP:0000919) | 1.86546361 |
| 90 | Metaphyseal irregularity (HP:0003025) | 1.86134543 |
| 91 | Abnormality of Sharpey fibers (HP:0100685) | 1.82962454 |
| 92 | Elevated alkaline phosphatase (HP:0003155) | 1.79981932 |
| 93 | Sensorimotor neuropathy (HP:0007141) | 1.78778991 |
| 94 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.77308590 |
| 95 | Metaphyseal dysplasia (HP:0100255) | 1.77096530 |
| 96 | Decreased circulating renin level (HP:0003351) | 1.75178303 |
| 97 | Nausea (HP:0002018) | 1.75107700 |
| 98 | Irritability (HP:0000737) | 1.74323308 |
| 99 | Tachypnea (HP:0002789) | 1.69201274 |
| 100 | Glomerulosclerosis (HP:0000096) | 1.67444727 |
| 101 | Abnormality of serum amino acid levels (HP:0003112) | 1.67288301 |
| 102 | Hypotension (HP:0002615) | 1.65854479 |
| 103 | Abnormality of carpal bone ossification (HP:0006257) | 1.62745462 |
| 104 | Neonatal onset (HP:0003623) | 1.62032469 |
| 105 | Focal segmental glomerulosclerosis (HP:0000097) | 1.59272537 |
| 106 | Abnormality of the renal medulla (HP:0100957) | 1.35609905 |
| 107 | Premature birth (HP:0001622) | 1.33828646 |
| 108 | Nephrogenic diabetes insipidus (HP:0009806) | 1.32727427 |
| 109 | Osteopenia (HP:0000938) | 1.32187445 |
| 110 | Paresthesia (HP:0003401) | 1.28745072 |
| 111 | Abnormality of macular pigmentation (HP:0008002) | 1.22572373 |
| 112 | Hypophosphatemic rickets (HP:0004912) | 1.19595269 |
| 113 | Intellectual disability, moderate (HP:0002342) | 1.18296937 |
| 114 | Abnormality of the fingertips (HP:0001211) | 1.18081734 |
| 115 | Abnormal eating behavior (HP:0100738) | 1.15234713 |
| 116 | Tubulointerstitial abnormality (HP:0001969) | 1.14389903 |
| 117 | Hyperkalemia (HP:0002153) | 1.12512087 |
| 118 | Thyroid-stimulating hormone excess (HP:0002925) | 1.09360880 |
| 119 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.06482670 |
| 120 | Hypothermia (HP:0002045) | 0.98797363 |
| 121 | Enlarged epiphyses (HP:0010580) | 0.97907566 |
| 122 | Polyhydramnios (HP:0001561) | 0.97161432 |
| 123 | Neonatal death (HP:0003811) | 0.91655673 |
| 124 | Osteomalacia (HP:0002749) | 0.90929818 |
| 125 | Chorioretinal atrophy (HP:0000533) | 0.87723813 |
| 126 | Small for gestational age (HP:0001518) | 0.86467983 |
| 127 | Stage 5 chronic kidney disease (HP:0003774) | 0.81608090 |
| 128 | Visceral angiomatosis (HP:0100761) | 0.77261691 |
| 129 | Esophageal varix (HP:0002040) | 0.74855282 |
| 130 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 0.73579462 |
| 131 | Abnormality of the renal cortex (HP:0011035) | 0.71637410 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK4 | 9.36301232 |
| 2 | WNK3 | 7.89363813 |
| 3 | OXSR1 | 7.57200222 |
| 4 | STK39 | 4.70889271 |
| 5 | BCKDK | 2.94366278 |
| 6 | STK38L | 2.46279288 |
| 7 | WNK1 | 2.04463715 |
| 8 | PDK4 | 1.94846270 |
| 9 | PDK3 | 1.94846270 |
| 10 | NEK1 | 1.94269413 |
| 11 | SGK223 | 1.81421605 |
| 12 | SGK494 | 1.81421605 |
| 13 | STK38 | 1.35204530 |
| 14 | PDK2 | 1.32280816 |
| 15 | MST1R | 1.20156645 |
| 16 | MST4 | 1.07287939 |
| 17 | SGK2 | 0.98712436 |
| 18 | FGFR4 | 0.94425852 |
| 19 | SGK3 | 0.93827844 |
| 20 | LRRK2 | 0.92654776 |
| 21 | PINK1 | 0.90050593 |
| 22 | EPHB1 | 0.79682723 |
| 23 | GRK6 | 0.79668396 |
| 24 | ARAF | 0.75792379 |
| 25 | GSK3A | 0.73257757 |
| 26 | PIM2 | 0.66056590 |
| 27 | MAP3K7 | 0.63647419 |
| 28 | SGK1 | 0.60114455 |
| 29 | DYRK1B | 0.57586277 |
| 30 | SMG1 | 0.55316400 |
| 31 | PTK2 | 0.53290153 |
| 32 | TIE1 | 0.53074129 |
| 33 | MAP3K3 | 0.51424910 |
| 34 | TGFBR2 | 0.50104790 |
| 35 | ABL2 | 0.48031109 |
| 36 | PRKAA1 | 0.46710117 |
| 37 | PAK4 | 0.45177089 |
| 38 | PKN1 | 0.45039641 |
| 39 | INSRR | 0.44871501 |
| 40 | MAPK11 | 0.42313412 |
| 41 | PDPK1 | 0.41417192 |
| 42 | ERN1 | 0.38965209 |
| 43 | PTK6 | 0.37764323 |
| 44 | TEC | 0.36862596 |
| 45 | PAK3 | 0.35866899 |
| 46 | MAP3K10 | 0.35088070 |
| 47 | PRKAA2 | 0.34369213 |
| 48 | PRKCI | 0.33522857 |
| 49 | MET | 0.32801834 |
| 50 | PRKD2 | 0.31548207 |
| 51 | FER | 0.29969878 |
| 52 | PRKCZ | 0.29362491 |
| 53 | STK11 | 0.28642060 |
| 54 | PTK2B | 0.28398479 |
| 55 | TRIB3 | 0.28246793 |
| 56 | STK10 | 0.27795587 |
| 57 | PDK1 | 0.27742786 |
| 58 | DDR2 | 0.27543129 |
| 59 | CAMK1 | 0.26620363 |
| 60 | MAP3K14 | 0.25943353 |
| 61 | LMTK2 | 0.25779798 |
| 62 | LATS2 | 0.25348873 |
| 63 | NTRK2 | 0.24605228 |
| 64 | FRK | 0.24507050 |
| 65 | FLT3 | 0.24009690 |
| 66 | NTRK1 | 0.23731666 |
| 67 | EPHB2 | 0.23168316 |
| 68 | RPS6KA2 | 0.22973912 |
| 69 | KDR | 0.22577419 |
| 70 | ERBB4 | 0.22529570 |
| 71 | NME2 | 0.22445433 |
| 72 | KIT | 0.21865937 |
| 73 | PRKCD | 0.21492045 |
| 74 | PIK3CG | 0.19727850 |
| 75 | RIPK1 | 0.19456431 |
| 76 | MAPK15 | 0.19110734 |
| 77 | MAP3K2 | 0.19109232 |
| 78 | GRK5 | 0.18949544 |
| 79 | MYLK | 0.18901620 |
| 80 | PRKCH | 0.17710530 |
| 81 | IRAK2 | 0.17657922 |
| 82 | LATS1 | 0.17562836 |
| 83 | PRKACG | 0.17103922 |
| 84 | MINK1 | 0.16202829 |
| 85 | EPHA4 | 0.15567942 |
| 86 | PKN2 | 0.15565268 |
| 87 | ADRBK2 | 0.14905379 |
| 88 | GRK1 | 0.14208935 |
| 89 | PIM1 | 0.13504173 |
| 90 | AKT2 | 0.13155404 |
| 91 | NLK | 0.12844149 |
| 92 | RPS6KL1 | 0.12754792 |
| 93 | RPS6KC1 | 0.12754792 |
| 94 | ERBB2 | 0.12653280 |
| 95 | PRKCA | 0.12228532 |
| 96 | BMX | 0.12002309 |
| 97 | NTRK3 | 0.10972911 |
| 98 | RPS6KA6 | 0.10622763 |
| 99 | RAF1 | 0.10420570 |
| 100 | PRKACA | 0.10217602 |
| 101 | IRAK3 | 0.09962958 |
| 102 | BRAF | 0.09342814 |
| 103 | JAK2 | 0.09169911 |
| 104 | MAP2K4 | 0.09073738 |
| 105 | ADRBK1 | 0.08475739 |
| 106 | SIK2 | 0.07742045 |
| 107 | PAK2 | 0.07267636 |
| 108 | MAPK7 | 0.07226004 |
| 109 | PRKCG | 0.06983355 |
| 110 | PRKD1 | 0.06943739 |
| 111 | MAPK3 | 0.06850317 |
| 112 | SCYL2 | 0.06774281 |
| 113 | MAP2K3 | 0.06602114 |
| 114 | INSR | 0.06047381 |
| 115 | SIK1 | 0.06010248 |
| 116 | MAPK12 | 0.05774444 |
| 117 | PRKCB | 0.05562794 |
| 118 | CAMKK2 | 0.05470026 |
| 119 | TRPM7 | 0.05215497 |
| 120 | PRKCE | 0.04990590 |
| 121 | ROCK1 | 0.04677281 |
| 122 | IRAK1 | 0.04534582 |
| 123 | SRC | 0.03277863 |
| 124 | PIK3CA | 0.03250002 |
| 125 | TESK1 | 0.02672439 |
| 126 | PRKCQ | 0.02154923 |
| 127 | MAPK10 | 0.02084253 |
| 128 | RET | 0.01756162 |
| 129 | DMPK | 0.01749750 |
| 130 | PRKG2 | 0.01613277 |
| 131 | CSK | 0.01547342 |
| 132 | MTOR | 0.00713986 |
| 133 | CAMK1G | 0.00554674 |
| 134 | MAP2K1 | 0.00494663 |
| 135 | PRKG1 | 0.00407729 |
| 136 | MAPK4 | 0.00088501 |
| 137 | CSNK1A1 | -0.0340254 |
| 138 | PRKD3 | -0.0329955 |
| 139 | NME1 | -0.0319293 |
| 140 | PDGFRA | -0.0305934 |
| 141 | DAPK2 | -0.0284635 |
| 142 | ABL1 | -0.0248033 |
| 143 | CSNK1G1 | -0.0215859 |
| 144 | PRKACB | -0.0131414 |
| 145 | CAMK4 | -0.0102835 |
| 146 | PNCK | -0.0053312 |
| 147 | IGF1R | -0.0052449 |
| 148 | RPS6KA3 | -0.0047238 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Butanoate metabolism_Homo sapiens_hsa00650 | 3.90797676 |
| 2 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.90370343 |
| 3 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.56567662 |
| 4 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 3.46375540 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.30841504 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.15636904 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 3.13832282 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.10851957 |
| 9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.92013506 |
| 10 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.49994939 |
| 11 | Peroxisome_Homo sapiens_hsa04146 | 2.49297873 |
| 12 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.49135882 |
| 13 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.49006764 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.34979348 |
| 15 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.27062301 |
| 16 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.18596332 |
| 17 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.06787628 |
| 18 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.06447900 |
| 19 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.03162794 |
| 20 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.00354977 |
| 21 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.99758177 |
| 22 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.94158617 |
| 23 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.80856910 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.76473841 |
| 25 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.69109341 |
| 26 | Carbon metabolism_Homo sapiens_hsa01200 | 1.64667611 |
| 27 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.63519997 |
| 28 | Bile secretion_Homo sapiens_hsa04976 | 1.61895719 |
| 29 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.61486923 |
| 30 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.58713455 |
| 31 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.46500816 |
| 32 | Other glycan degradation_Homo sapiens_hsa00511 | 1.38712673 |
| 33 | Lysine degradation_Homo sapiens_hsa00310 | 1.29852543 |
| 34 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.24542129 |
| 35 | Mineral absorption_Homo sapiens_hsa04978 | 1.22534094 |
| 36 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.18994665 |
| 37 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.16944006 |
| 38 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.13000290 |
| 39 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.12949339 |
| 40 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.12486409 |
| 41 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.11633277 |
| 42 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.09025133 |
| 43 | Histidine metabolism_Homo sapiens_hsa00340 | 1.07665522 |
| 44 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.04872983 |
| 45 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.02653425 |
| 46 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.00965041 |
| 47 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.95943912 |
| 48 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.93513854 |
| 49 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.93454879 |
| 50 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.93132438 |
| 51 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.88111450 |
| 52 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.87566870 |
| 53 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.80158510 |
| 54 | Endometrial cancer_Homo sapiens_hsa05213 | 0.75682722 |
| 55 | Melanoma_Homo sapiens_hsa05218 | 0.74661441 |
| 56 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.69990088 |
| 57 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.68906031 |
| 58 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.67940382 |
| 59 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.67229431 |
| 60 | Gap junction_Homo sapiens_hsa04540 | 0.67035786 |
| 61 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.65930314 |
| 62 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.64348951 |
| 63 | Lysosome_Homo sapiens_hsa04142 | 0.63671123 |
| 64 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.62046539 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.61111136 |
| 66 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.59508755 |
| 67 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.59178553 |
| 68 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.58040921 |
| 69 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.55597656 |
| 70 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.54418303 |
| 71 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.54345520 |
| 72 | Metabolic pathways_Homo sapiens_hsa01100 | 0.52861345 |
| 73 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.51134878 |
| 74 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.50095737 |
| 75 | Hepatitis C_Homo sapiens_hsa05160 | 0.49873428 |
| 76 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.48958788 |
| 77 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.45865675 |
| 78 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.44264362 |
| 79 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.37428462 |
| 80 | Glioma_Homo sapiens_hsa05214 | 0.37218275 |
| 81 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.36961729 |
| 82 | Retinol metabolism_Homo sapiens_hsa00830 | 0.36267577 |
| 83 | Parkinsons disease_Homo sapiens_hsa05012 | 0.36005396 |
| 84 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.34894740 |
| 85 | Renin secretion_Homo sapiens_hsa04924 | 0.32553836 |
| 86 | Focal adhesion_Homo sapiens_hsa04510 | 0.32414661 |
| 87 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.32409931 |
| 88 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.32308081 |
| 89 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.31201887 |
| 90 | Salivary secretion_Homo sapiens_hsa04970 | 0.30233071 |
| 91 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.29976233 |
| 92 | ABC transporters_Homo sapiens_hsa02010 | 0.29366877 |
| 93 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.28034838 |
| 94 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.24608092 |
| 95 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.24290113 |
| 96 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.23230846 |
| 97 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.22954314 |
| 98 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.21652889 |
| 99 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.21447813 |
| 100 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.21133903 |
| 101 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.21066158 |
| 102 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.18093166 |
| 103 | Sulfur relay system_Homo sapiens_hsa04122 | 0.17796366 |
| 104 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.16012922 |
| 105 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.15452916 |
| 106 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.12527964 |
| 107 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.12242113 |
| 108 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.11635550 |
| 109 | Morphine addiction_Homo sapiens_hsa05032 | 0.11466468 |
| 110 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.11008415 |
| 111 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.10995894 |
| 112 | Prostate cancer_Homo sapiens_hsa05215 | 0.10847141 |
| 113 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.08095479 |
| 114 | Alzheimers disease_Homo sapiens_hsa05010 | 0.07545925 |
| 115 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.07532641 |
| 116 | Insulin resistance_Homo sapiens_hsa04931 | 0.07278228 |
| 117 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.06974391 |
| 118 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.05640143 |
| 119 | Galactose metabolism_Homo sapiens_hsa00052 | 0.02609576 |
| 120 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.00288560 |
| 121 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | -0.0867224 |
| 122 | One carbon pool by folate_Homo sapiens_hsa00670 | -0.0778790 |
| 123 | Bladder cancer_Homo sapiens_hsa05219 | -0.0674110 |
| 124 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0410474 |
| 125 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0378295 |
| 126 | Huntingtons disease_Homo sapiens_hsa05016 | -0.0338245 |
| 127 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | -0.0080512 |

